Natural Alternatives International (NASDAQ:NAII) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Natural Alternatives International (NASDAQ:NAII) in a research report sent to investors on Tuesday. The firm issued a buy rating on the stock.

Natural Alternatives International Trading Up 6.3 %

Shares of NAII opened at $4.56 on Tuesday. The stock’s 50-day moving average price is $4.83 and its 200 day moving average price is $5.61. The company has a quick ratio of 1.50, a current ratio of 2.56 and a debt-to-equity ratio of 0.11. The firm has a market capitalization of $28.27 million, a price-to-earnings ratio of -3.17 and a beta of 0.58. Natural Alternatives International has a 12-month low of $4.11 and a 12-month high of $7.37.

Natural Alternatives International (NASDAQ:NAII) last released its quarterly earnings data on Friday, September 27th. The company reported ($0.32) earnings per share (EPS) for the quarter. The firm had revenue of $29.49 million for the quarter. Natural Alternatives International had a negative net margin of 7.53% and a negative return on equity of 10.23%.

Institutional Trading of Natural Alternatives International

A hedge fund recently raised its stake in Natural Alternatives International stock. Geode Capital Management LLC increased its holdings in Natural Alternatives International, Inc. (NASDAQ:NAII) by 6.9% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 45,062 shares of the company’s stock after purchasing an additional 2,915 shares during the period. Geode Capital Management LLC owned approximately 0.73% of Natural Alternatives International worth $258,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 32.40% of the company’s stock.

About Natural Alternatives International

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.